Results 31 to 40 of about 548,791 (262)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
Disorders of endocrine, reproductive and skeletal systems following allogeneic or autologous stem cell transplantation for hematological malignancies in adults [PDF]
, 2006 Introduzione Il progressivo aumento del numero dei pazienti sopravviventi a lungo termine dopo la guarigione da malignità emopoietiche ha portato a focalizzare l’attenzione sulle complicanze precoci e tardive delle malattie e dei loro trattamenti.
Tauchmanova, Libuse
core +1 more source
Current Issues in Molecular BiologyMicroRNAs are key regulators of lymphoid differentiation, exhibiting a pivotal role in acute lymphoblastic leukemia (ALL) biology and prognosis. The initial steps of canonical miRNA biogenesis involve the microprocessor complex processing the primary ...
Ioannis Kyriakidis +4 more
doaj +1 more source
A survey on cellular and engineered tissue therapies in Europe in 2008 [PDF]
, 2010 Cellular therapy is an evolving investigational treatment modality in regenerative medicine, but little published information is available on its current use.
Martin, Ivan +4 more
core +1 more source
, 2023 Background: Retinoblastoma (RB) is the most common intraocular malignancy in childhood. Advanced RB, associated with exceedingly poor prognosis, requires more intensive multiagent chemotherapy than conventional regimens.
TÖRET, ERSİN +12 more
core +1 more source
Organoids in pediatric cancer research
FEBS Letters, EarlyView.Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley +1 more source
Clinical Allogeneic and Autologous Islet Cell Transplantation: Update [PDF]
Diabetes & Metabolism Journal, 2011 Islet cell transplantation is categorized as a β-cell replacement therapy for diabetic patients who lack the ability to secrete insulin. Allogeneic islet cell transplantation is for the treatment of type 1 diabetes, and autologous islet cell ...
Shinichi Matsumoto
doaj +1 more source
Second allogeneic transplantation after failure of first autologous transplantation [PDF]
, 2000 We evaluated the outcome of second allogeneic bone marrow transplantations (BMTs) in 59 patients aged 1-57 years who relapsed after initial autologous transplantation. Patients received a second transplantation for recurrent acute myeloid leukemia (AML) (
Anasetti, Claudio +5 more
core +1 more source
Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system
FEBS Letters, EarlyView.Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley +1 more source
Haematologica, 2014 Allogeneic stem cell transplantation is the standard approach to Philadelphia chromosome positive acute lymphoblastic leukemia. We hypothesized that imatinib plus sequential chemotherapy will result in significant leukemia cell cytoreduction in patients ...
Meir Wetzler +12 more
doaj +1 more source